Cargando…

The Influence of SARS-CoV-2 Infection on Lipid Metabolism—The Potential Use of Lipid-Lowering Agents in COVID-19 Management

Several studies have indicated lipid metabolism alterations during COVID-19 infection, specifically a decrease in high-density lipoprotein (HDL) and low-density lipoprotein (LDL) concentrations and an increase in triglyceride (TG) levels during the infection. However, a decline in triglycerides can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowalska, Klaudia, Sabatowska, Zofia, Forycka, Joanna, Młynarska, Ewelina, Franczyk, Beata, Rysz, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496398/ https://www.ncbi.nlm.nih.gov/pubmed/36140421 http://dx.doi.org/10.3390/biomedicines10092320

Ejemplares similares

The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder
por: Młynarska, Ewelina, et al.
Publicado: (2022)

Empagliflozin—A New Chance for Patients with Chronic Heart Failure
por: Kowalska, Klaudia, et al.
Publicado: (2021)

New Insights into the Use of Empagliflozin—A Comprehensive Review
por: Forycka, Joanna, et al.
Publicado: (2022)

The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
por: Kowalska, Klaudia, et al.
Publicado: (2022)

The Influence of Lifestyle and Treatment on Oxidative Stress and Inflammation in Diabetes
por: Wronka, Magdalena, et al.
Publicado: (2022)

Molecular Interactions of Arterial Hypertension in Its Target Organs
por: Kućmierz, Joanna, et al.
Publicado: (2021)

What Is the Role of Gut Microbiota in Obesity Prevalence? A Few Words about Gut Microbiota and Its Association with Obesity and Related Diseases
por: Tokarek, Julita, et al.
Publicado: (2021)

New Insights into the Nephroprotective Potential of Lercanidipine
por: Hajdys, Joanna, et al.
Publicado: (2023)

New Insights into Molecular Mechanisms of Chronic Kidney Disease
por: Frąk, Weronika, et al.
Publicado: (2022)

Acute Kidney Injury in COVID-19
por: Głowacka, Marta, et al.
Publicado: (2021)

Arterial Hypertension—Oxidative Stress and Inflammation
por: Krzemińska, Julia, et al.
Publicado: (2022)

Rhabdomyolysis-Induced AKI (RIAKI) Including the Role of COVID-19
por: Młynarska, Ewelina, et al.
Publicado: (2022)

Chronic Kidney Disease as a Comorbidity in Heart Failure
por: Szlagor, Magdalena, et al.
Publicado: (2023)

Structural and Functional Changes in Aging Kidneys
por: Dybiec, Jill, et al.
Publicado: (2022)

New Insights into the Use of Liraglutide—Impact on Cardiovascular Risk and Microvascular Outcomes
por: Wronka, Magdalena, et al.
Publicado: (2023)

Does the Composition of Gut Microbiota Affect Hypertension? Molecular Mechanisms Involved in Increasing Blood Pressure
por: Tokarek, Julita, et al.
Publicado: (2023)

Cardiovascular Diseases: Therapeutic Potential of SGLT-2 Inhibitors
por: Frąk, Weronika, et al.
Publicado: (2023)

Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease
por: Frąk, Weronika, et al.
Publicado: (2022)

Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab
por: Krzemińska, Julia, et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease
por: Baran, Wiktoria, et al.
Publicado: (2021)

Novel Insights into the Molecular Mechanisms of Atherosclerosis
por: Wojtasińska, Armanda, et al.
Publicado: (2023)

Cellular Mechanisms of Coronary Artery Spasm
por: Franczyk, Beata, et al.
Publicado: (2022)

Advances in the Pathogenesis and Treatment of Resistant Hypertension
por: Dybiec, Jill, et al.
Publicado: (2023)

Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes
por: Tokarek, Julita, et al.
Publicado: (2023)

Advances in Treatment of Dyslipidemia
por: Dybiec, Jill, et al.
Publicado: (2023)

Statins in Chronic Kidney Disease—Effects on Atherosclerosis and Cellular Senescence
por: Fularski, Piotr, et al.
Publicado: (2023)

Novel Therapeutic Approaches in the Management of Chronic Kidney Disease
por: Dąbek, Bartłomiej, et al.
Publicado: (2023)

The Influence of Inflammation on Anemia in CKD Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2020)

The Influence of Dietary Interventions on Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
por: Rysz, Jacek, et al.
Publicado: (2021)

The Effect of Diet on the Survival of Patients with Chronic Kidney Disease
por: Rysz, Jacek, et al.
Publicado: (2017)

Pharmacogenomics of Hypertension Treatment
por: Rysz, Jacek, et al.
Publicado: (2020)

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
por: Rysz, Jacek, et al.
Publicado: (2020)

Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake
por: Rysz, Jacek, et al.
Publicado: (2021)

Are Alterations in DNA Methylation Related to CKD Development?
por: Rysz, Jacek, et al.
Publicado: (2022)

The Role of Inflammation and Oxidative Stress in Rheumatic Heart Disease
por: Franczyk, Beata, et al.
Publicado: (2022)

Vegetarian Diet in Chronic Kidney Disease—A Friend or Foe
por: Gluba-Brzózka, Anna, et al.
Publicado: (2017)

Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients
por: Gluba-Brzozka, Anna, et al.
Publicado: (2019)

Pharmacogenetics of Drugs Used in the Treatment of Cancers
por: Franczyk, Beata, et al.
Publicado: (2022)

High-Sensitivity C-Reactive Protein Relationship with Metabolic Disorders and Cardiovascular Diseases Risk Factors
por: Koziarska-Rościszewska, Małgorzata, et al.
Publicado: (2021)

The Role of Metabolic Factors in Renal Cancers
por: Rysz, Jacek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_abqhpsbftm6849kljsd28rra8s